Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy

Abstract

Renal cell carcinoma (RCC) is known for its ability to metastasize synchronously or metachronously to various anatomic sites. Distinguishing histologic subtypes of metastatic RCC has become increasingly important, as prognosis and therapy can differ dramatically between subtypes. We propose a combination of immunohistochemistry (IHC) and molecular… (More)
DOI: 10.1186/1476-4598-13-39

Topics

4 Figures and Tables